ISU Abxis Co., Ltd. (KOSDAQ: A086890)
Health Care · Biotechnology · KR
₩3,980.00
+3.51% today · -22.0% 1Y
ISU Abxis Co., Ltd. (KOSDAQ: A086890) operates in the Biotechnology industry within the Health Care sector. The company is valued at $120.71M.
Over the last twelve months the share price has lost 22.0%, trading between 2.89K and 6.35K.
Tweenvest scores ISU Abxis Co., Ltd. across four factors: quality 60/100, value 67/100, growth 69/100. Its strongest factor is growth.
A086890 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $120.71M
- Revenue (TTM)
- $32.96M
- P/E
- —
- EPS
- -308.30
- Dividend yield
- —
- Beta (5Y)
- 0.38
- 52-week high
- ₩6,350.00
- 52-week low
- ₩2,890.00
- Avg volume (3M)
- —
- Shares outstanding
- 40.77M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Sunho Biologics, Inc.SEHK: 2898 | $123.78M | HK$— | — |
| Cereno Scientific AB (publ)OM: CRNO B | $123.72M | Skr3.82 | -5.59% |
| BRIM Biotechnology, Inc.TWSE: 6885 | $123.18M | NT$29.60 | -2.63% |
| Kazia Therapeutics LimitedNasdaqCM: KZIA | $122.37M | $8.30 | -7.05% |
| Anterogen.Co.,Ltd.KOSDAQ: A065660 | $120.50M | ₩16,190.00 | +7.65% |
| Foghorn Therapeutics Inc.NasdaqGM: FHTX | $118.77M | $1.89 | -5.50% |
| Cibus, Inc.NasdaqCM: CBUS | $118.46M | $1.43 | -8.06% |
| Nykode Therapeutics ASOB: NYKD | $117.42M | Nkr3.20 | -6.98% |
Figures last refreshed Oct 11, 2026.